Department of Pediatrics, Hamad Medical Centre, Doha, Qatar.
J Trop Pediatr. 2009 Oct;55(5):324-7. doi: 10.1093/tropej/fmp011. Epub 2009 Mar 4.
We measured growth [length (L) standard deviation score (SDS), growth velocity (GV) SDS and body mass index (BMI)] and hematological (hemoglobin, hematocrit, MCV and MCH) parameters in 40 children (aged 17.2 +/- 12.4 months) with iron deficiency anemia (IDA) before and after iron therapy. Before treatment children with IDA had LSDS = -1.2 +/- 1, GV = 7.5 +/- 2.2, GVSDS = -1.42 +/- 0.6 and BMI = 13.5 +/- 1.2. They were significantly shorter and had reduced growth as compared with age-matched controls. After treatment, their growth parameters significantly increased with LSDS = -0.6 +/- -0.9, GV = 13.2 +/- 4.4 cm year(-1), GVSDS = 1.7 +/- 0.5 and BMI = 14.2 +/- 1.1. Their GV correlated significantly with serum ferritin concentration (r = 0.48, p < 0.001) and BMI (r = 0.32, p < 0.1). In summary, IDA during the first 2 years of life significantly impairs growth.
我们测量了 40 名患有缺铁性贫血(IDA)的儿童(年龄为 17.2 ± 12.4 个月)在铁治疗前后的生长(长度(L)标准差评分(SDS)、生长速度(GV)SDS 和体重指数(BMI))和血液学参数(血红蛋白、血细胞比容、MCV 和 MCH)。在治疗前,IDA 患儿的 LSDS = -1.2 ± 1,GV = 7.5 ± 2.2,GVSDS = -1.42 ± 0.6,BMI = 13.5 ± 1.2。与同龄对照组相比,他们明显更矮,生长速度较慢。治疗后,他们的生长参数明显增加,LSDS = -0.6 ± -0.9,GV = 13.2 ± 4.4 cm/年,GVSDS = 1.7 ± 0.5,BMI = 14.2 ± 1.1。他们的 GV 与血清铁蛋白浓度(r = 0.48,p < 0.001)和 BMI(r = 0.32,p < 0.1)呈显著相关。总之,生命前 2 年的 IDA 显著影响生长。